Dow Down1.29% Nasdaq Down3.25%

More On TEVA


Teva Pharmaceutical Industries Limited (TEVA)

-NYSE
58.86 Down 1.04(1.74%) Feb 5, 4:02PM EST
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):1.9
Mean Recommendation (last week):1.9
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:77.43
Median Target:77.00
High Target:100.00
Low Target:65.00
No. of Brokers:23

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Nov 23, 2015GoldmanUpgradeNeutralBuy
Sep 29, 2015NomuraInitiated Neutral
Aug 5, 2015BerenbergUpgradeSellHold
Jun 3, 2015Raymond JamesInitiated Mkt Perform
Apr 29, 2015Standpoint ResearchUpgradeHoldBuy
Apr 8, 2015Standpoint ResearchDowngradeBuyHold
Mar 31, 2015OppenheimerUpgradePerformOutperform
Oct 14, 2014Standpoint ResearchUpgradeHoldBuy
Oct 2, 2014Standpoint ResearchDowngradeBuyHold
Jun 27, 2014Canaccord GenuityInitiated Hold

More Upgrades & Downgrades for TEVA

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy9988
Buy9988
Hold6688
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.